Charles Weston
Stock Analyst at RBC Capital
(0.30)
# 4,565
Out of 5,099 analysts
342
Total ratings
39.1%
Success rate
-4.3%
Average return
Main Sectors:
Stocks Rated by Charles Weston
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LON: CTEC Convatec Group PLC | Reiterated: Buy | 315p | 244p | +29.31% | 16 | Nov 4, 2026 | |
| LON: CVSG CVS Group plc | Reiterated: Buy | 1,900p → 1,800p | 1,367p | +31.68% | 24 | Nov 3, 2026 | |
| ETR: EVT Evotec SE | Reiterated: Buy | €10.00 → €5.00 | €2.86 | +74.83% | 56 | Oct 30, 2026 | |
| ETR: SRT3 Sartorius Aktiengesellschaft | Reiterated: Hold | €220.00 | €292.70 | -24.84% | 25 | Oct 22, 2026 | |
| EPA: DIM Sartorius Stedim Biotech S.A. | Reiterated: Buy | €210.00 → €275.00 | €223.40 | +23.10% | 24 | Oct 22, 2026 | |
| LON: ONT Oxford Nanopore Technologies plc | Reiterated: Buy | 225p → 300p | 216p | +39.02% | 32 | Sep 30, 2026 | |
| AIM: 4BB 4basebio PLC | Reiterated: Buy | 1,400p → 1,000p | 500p | +100.00% | 5 | Sep 28, 2026 | |
| LON: OXB Oxford Biomedica plc | Reiterated: Buy | 900p | 545p | +65.14% | 33 | Sep 28, 2026 | |
| BIT: 1SXP SCHOTT Pharma AG & Co. KGaA | Reiterated: Buy | €21.00 | €24.50 | -14.29% | 9 | Aug 12, 2026 | |
| ETR: AFX Carl Zeiss Meditec AG | Reiterated: Hold | €32.00 | €35.00 | -8.57% | 2 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | 1,350p → 1,250p | 1,118p | +11.86% | 2 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | CHF 760.00 | CHF 652.20 | +16.53% | 40 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | CHF 110.00 | CHF 80.80 | +36.14% | 12 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | CHF 44.00 | CHF 42.60 | +3.29% | 9 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | CHF 108.00 → CHF 96.00 | CHF 72.00 | +33.33% | 16 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $79.21 | - | 1 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $280 | $105.95 | n/a | 1 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 310p | 248p | n/a | 20 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | CHF 26.00 | CHF 2.60 | n/a | 4 | Jul 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | kr 287.00 | kr 38.62 | n/a | 2 | Apr 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 160p | 75p | n/a | 1 | Nov 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6.81 | $0.1584 | n/a | 8 | Apr 24, 2018 |
Convatec Group PLC
Nov 4, 2026
Reiterated: Buy
Price Target: 315p
Current: 244p
Upside: +29.31%
CVS Group plc
Nov 3, 2026
Reiterated: Buy
Price Target: 1,900p → 1,800p
Current: 1,367p
Upside: +31.68%
Evotec SE
Oct 30, 2026
Reiterated: Buy
Price Target: €10.00 → €5.00
Current: €2.86
Upside: +74.83%
Sartorius Aktiengesellschaft
Oct 22, 2026
Reiterated: Hold
Price Target: €220.00
Current: €292.70
Upside: -24.84%
Sartorius Stedim Biotech S.A.
Oct 22, 2026
Reiterated: Buy
Price Target: €210.00 → €275.00
Current: €223.40
Upside: +23.10%
Oxford Nanopore Technologies plc
Sep 30, 2026
Reiterated: Buy
Price Target: 225p → 300p
Current: 216p
Upside: +39.02%
4basebio PLC
Sep 28, 2026
Reiterated: Buy
Price Target: 1,400p → 1,000p
Current: 500p
Upside: +100.00%
Oxford Biomedica plc
Sep 28, 2026
Reiterated: Buy
Price Target: 900p
Current: 545p
Upside: +65.14%
SCHOTT Pharma AG & Co. KGaA
Aug 12, 2026
Reiterated: Buy
Price Target: €21.00
Current: €24.50
Upside: -14.29%
Carl Zeiss Meditec AG
Aug 6, 2026
Reiterated: Hold
Price Target: €32.00
Current: €35.00
Upside: -8.57%
Aug 6, 2026
Reiterated: Hold
Price Target: 1,350p → 1,250p
Current: 1,118p
Upside: +11.86%
Aug 3, 2026
Reiterated: Buy
Price Target: CHF 760.00
Current: CHF 652.20
Upside: +16.53%
Jul 31, 2026
Reiterated: Buy
Price Target: CHF 110.00
Current: CHF 80.80
Upside: +36.14%
Jul 7, 2026
Downgraded: Hold
Price Target: CHF 44.00
Current: CHF 42.60
Upside: +3.29%
Mar 16, 2026
Reiterated: Hold
Price Target: CHF 108.00 → CHF 96.00
Current: CHF 72.00
Upside: +33.33%
Feb 11, 2026
Upgraded: Buy
Price Target: n/a
Current: $79.21
Upside: -
Jan 7, 2025
Reiterated: Buy
Price Target: $280
Current: $105.95
Upside: n/a
Nov 19, 2024
Reiterated: Buy
Price Target: 310p
Current: 248p
Upside: n/a
Jul 12, 2021
Reiterated: Buy
Price Target: CHF 26.00
Current: CHF 2.60
Upside: n/a
Apr 13, 2021
Reiterated: Buy
Price Target: kr 287.00
Current: kr 38.62
Upside: n/a
Nov 2, 2018
Reiterated: Buy
Price Target: 160p
Current: 75p
Upside: n/a
Apr 24, 2018
Reiterated: Buy
Price Target: $6.81
Current: $0.1584
Upside: n/a